Although from a correlative, small-scale gene expression study, and requiring confirmation in larger studies, our findings suggest that FXR/BRD4 function is likely dysregulated in the PBC patients and that this impaired function may contribute to inflammatory and fibrotic pathologies in the patients. The gene discussed is BRD4; the disease is primary biliary cholangitis.